Literature DB >> 33199289

Mass testing for covid-19 in the UK.

Mike Gill1, Muir Gray2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33199289     DOI： 10.1136/bmj.m4436

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

Review 1.  Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy.

Authors:  Zhaomin Feng; Yi Zhang; Yang Pan; Daitao Zhang; Lei Zhang; Quanyi Wang
Journal:  Med Rev (Berl)       Date:  2022-04-28

2.  Sleep and circadian phenotypes: risk factors for COVID-19 severity?

Authors:  Lei Gao; Peng Li; Jacqueline M Lane
Journal:  Sleep       Date:  2022-07-11       Impact factor: 6.313

3.  Validation testing to determine the sensitivity of lateral flow testing for asymptomatic SARS-CoV-2 detection in low prevalence settings: Testing frequency and public health messaging is key.

Authors:  Jack Ferguson; Steven Dunn; Angus Best; Jeremy Mirza; Benita Percival; Megan Mayhew; Oliver Megram; Fiona Ashford; Thomas White; Emma Moles-Garcia; Liam Crawford; Tim Plant; Andrew Bosworth; Michael Kidd; Alex Richter; Jonathan Deeks; Alan McNally
Journal:  PLoS Biol       Date:  2021-04-29       Impact factor: 8.029

4.  Health Care Professionals' Confidence and Preferences for Diagnostic Assays for SARS-CoV-2: A Global Study.

Authors:  Adrian M Shields; Hannah Brown; Neil Phillips; Mark T Drayson; Anton A Richter; Alex G Richter
Journal:  Front Public Health       Date:  2021-02-26

5.  Students' Views towards Sars-Cov-2 Mass Asymptomatic Testing, Social Distancing and Self-Isolation in a University Setting during the COVID-19 Pandemic: A Qualitative Study.

Authors:  Holly Blake; Holly Knight; Ru Jia; Jessica Corner; Joanne R Morling; Chris Denning; Jonathan K Ball; Kirsty Bolton; Grazziela Figueredo; David E Morris; Patrick Tighe; Armando Mendez Villalon; Kieran Ayling; Kavita Vedhara
Journal:  Int J Environ Res Public Health       Date:  2021-04-15       Impact factor: 3.390

6.  Mass Testing With Contact Tracing Compared to Test and Trace for the Effective Suppression of COVID-19 in the United Kingdom: Systematic Review.

Authors:  Mathew Mbwogge
Journal:  JMIRx Med       Date:  2021-04-12

7.  Feasibility and Acceptability of Community Coronavirus Disease 2019 Testing Strategies (FACTS) in a University Setting.

Authors:  Jennifer A Hirst; Mary Logan; Thomas R Fanshawe; Lazaro Mwandigha; Marta Wanat; Charles Vicary; Rafael Perera; Sarah Tonkin-Crine; Joseph Jonathan Lee; Irene Tracey; Gordon Duff; Peter Tufano; Marya Besharov; Lionel Tarassenko; Brian D Nicholson; F D Richard Hobbs
Journal:  Open Forum Infect Dis       Date:  2021-10-04       Impact factor: 3.835

8.  Rapid SARS-CoV-2 Intra-Host and Within-Household Emergence of Novel Haplotypes.

Authors:  Laura Manuto; Marco Grazioli; Andrea Spitaleri; Paolo Fontana; Luca Bianco; Luigi Bertolotti; Martina Bado; Giorgia Mazzotti; Federico Bianca; Francesco Onelia; Giovanni Lorenzin; Fabio Simeoni; Dejan Lazarevic; Elisa Franchin; Claudia Del Vecchio; Ilaria Dorigatti; Giovanni Tonon; Daniela Maria Cirillo; Enrico Lavezzo; Andrea Crisanti; Stefano Toppo
Journal:  Viruses       Date:  2022-02-15       Impact factor: 5.048

9.  Implementation of novel and conventional outbreak control measures in managing COVID-19 outbreaks in a large UK prison.

Authors:  Paul C Coleman; Adam Pailing; Anjana Roy; Éamonn O'Moore; Joht Singh Chandan; Victoria Lumby; Paul Newton; Anna Taylor; Esther Robinson; Jonathon Swindells; Sarah Dowle; Roger Gajraj
Journal:  BMC Public Health       Date:  2022-04-07       Impact factor: 3.295

10.  Impact of the COVID-19 pandemic on access to the cerliponase alfa managed access agreement in England for CLN2 treatment.

Authors:  Amanda Mortensen; Eva M Raebel; Samantha Wiseman
Journal:  Orphanet J Rare Dis       Date:  2022-01-19       Impact factor: 4.123
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.